Category: Cancer Awareness

Newsletter Kapa3| June 2026,From survivorship to quality of life — from information to support — from technology to human-centred care.

May was a month of important developments, scientific outreach and service enhancement for Kapa3. From the new European scientific publication of the MELODIC project and educational participation in international networks, to the development of “Myrto”, the creation of a new Psychological Support Team and support through social and corporate initiatives, Kapa3 continues to bring together knowledge, technology, human care and social action.

Our mission remains focused on equal access for cancer patients and their caregivers to information, rights, services and meaningful support.

1. June: Cancer Survivors Month

June is dedicated to people living with and beyond cancer. Survivorship is not only the end of treatment; it is continuity, adaptation, reintegration, psychosocial support, quality of life and the right to care beyond therapy.

▸ EN: https://www.kapa3.gr/en/june-cancer-survivors-month-title-sep-sitename/

2. Kapa3 Introduces Its New Psychological Support Team

On the occasion of Mental Health Awareness Month and Cancer Survivors Month, Kapa3 introduces its new Psychological Support Team: a safe space for listening, support and empowerment for patients, survivors, caregivers and families.

▸ CONTACT US  https://www.kapa3.gr/en/kapa3-introduces-its-new-psychological-support-team/

3. New MELODIC Scientific Publication on the Mental Health of Young Adults with Cancer

Mental health is an integral part of cancer care, particularly for young adults facing the complex challenges of a cancer diagnosis. Kapa3 contributes to the new scientific publication of the European MELODIC project, highlighting the educational needs of healthcare professionals.

▸ READ THE ARTICLE

4. Digital Health and Cancer Survivorship: Kapa3 at the INE-CSC 2026 Conference in Coimbra

Kapa3 participated in the INE-CSC 2026 Conference in Coimbra, contributing to the European dialogue on cancer survivorship, supportive care, digital health and participatory solutions that respond to the real needs of patients and caregivers.

▸ READ THE ARTICL Ehttps://www.kapa3.gr/en/participation-in-ca21152-implementation-network-europe-for-cancer-survivorship-care/

5. Co-creating Myrto: A Digital Health and Rights Navigator for Oncology Patients

Myrto is designed as a digital health and rights navigator — a Patient Empowerment e-Navigator — that goes beyond information provision to guide, support and evolve according to users’ real needs.

▸ READ THE ARTICLE https://www.kapa3.gr/en/myrto-health-navigator-oncology-patients-greece/

6. Learning by Doing: Participation in the European Service Learning 2.0: CoLab Programme

Kapa3 participated in the European programme Service Learning 2.0: CoLab, an initiative connecting academic knowledge with meaningful social action and highlighting collaboration between universities, civil society organisations and community actors.

▸ FIND OUT MOREhttps://www.kapa3.gr/en/learning-by-doing-participation-in-the-european-service-learning-2-0-colab-programme/

7. Alpha Bank and Its Employees Support Kapa3 through the Match for Good Initiative

Through the Match for Good initiative, Alpha Bank and its employees supported Kapa3, strengthening our mission to stand alongside people affected by cancer, their families and caregivers.

▸ FIND OUT MORE https://www.kapa3.gr/en/i-alpha-bank-kai-oi-ergazomenoi-tis-stirizoyn-to-kapa3-kai-tin-isotimi-prosvasi-stin-ypostirixi-ton-ogkologikon-asthenon/

8. 6 Awards for Kapa3 at the 4th Vouliagmeni Summer Crossing: Is There Such a Thing as a “Lonely Race”?

Kapa3 took part in the 4th Vouliagmeni Summer Crossing, sharing a strong message of participation, resilience, empowerment and solidarity. Even when a race seems individual, it does not have to be lonely.

▸ READ MOREhttps://www.kapa3.gr/en/kapa3-6-vraveia-diaplous-vouliagmenis/

Newsletter closing note

If this newsletter reached you through forwarding or another source, subscribe today to receive reliable updates, news and useful information directly in your inbox.

Support our work and help us continue to provide information, guidance and support to patients and their families.

▸ SUBSCRIBE TO NEWSLETTER

▸ SUPPORT US

Participation in CA21152 – Implementation Network Europe for Cancer Survivorship Care

Digital Health and Cancer Survivorship: Kapa3 at the INE-CSC 2026 Conference in Coimbra

The Cancer Guidance Center – Kapa3 participated in the INE-CSC 2026 Conference, part of CA21152 – Implementation Network Europe for Cancer Survivorship Care (INE-CSC), held on 25–26 May 2026 at the Faculty of Medicine (Polo III), University of Coimbra, in Coimbra, Portugal.

The conference was held under the theme “The Next Chapter – Empowering Individuals, Families, and Society for Cancer Survivorship & Supportive Care”, highlighting the need for new approaches to cancer survivorship, supportive care and the translation of innovation into real-world impact for people living with and beyond cancer, their families and society.

Kapa3’s presence in Coimbra represents another important step in its European engagement and in its ongoing effort to connect everyday experience in supporting cancer patients in Greece with European knowledge, research, digital innovation and health policy.

A key highlight was the participation in a round table discussion on facilitators and barriers to the implementation of digital health tools in oncology. The discussion was co-organised by Aristea Kyriaki Ladas and Christos Frantzidis and brought together voices from different European countries and organisations, including representatives from Kapa3, Acreditar Portugal, Liga Portuguesa Contra o Cancro, ORCO / Madrid Regional Ministry of Health, as well as participants from Poland, Latvia and the United Kingdom.

Among the participants in the round table were Yannis Kontogiorgis and Despoina Pistiolis from Kapa3, Greece, contributing to the European dialogue on digital health, oncology navigation and the participatory development of solutions that respond to the real needs of patients and caregivers.

One of the key messages of the discussion was that digital innovation in oncology is not only a technological challenge. It is also a matter of policy, implementation, equity, trust and accessibility.

For digital tools to make a meaningful difference in cancer care and survivorship, they cannot remain isolated applications or pilot projects. They need to become part of real care pathways, be supported by appropriate policy environments, connect with interdisciplinary practice and be evaluated in terms of effectiveness, implementation readiness, accessibility, equity, sustainability and value.

The discussion also highlighted that digital tools must be designed around the real needs of patients and survivors, not only around technical possibilities. Accessibility across countries, languages, healthcare systems and levels of digital and health literacy must be built in from the beginning.

The role of patient organisations and cancer support communities was also identified as essential. These organisations can act as a bridge between technological innovation and the everyday reality of people affected by cancer. They understand the questions, barriers, fears and needs that are often not fully captured by formal care systems.

For Kapa3, this participation is directly linked to the development of Myrto, its digital health and rights navigator, designed as a tool for empowerment, guidance and support for cancer patients and their caregivers.

Myrto is not approached as a simple information tool. It is being designed as a participatory intervention built around the real needs of people with lived experience of cancer. It is connected to access to rights, social benefits, services, practical guidance and human escalation whenever needed.

The Coimbra experience strengthened the view that digital health must be human-centred, accessible, trustworthy and integrated into a broader ecosystem of care. Technology can meaningfully support cancer care only when it is designed with participation, trust, clear purpose and an equity-oriented approach.

Cancer survivorship is not only about completing treatment. It is about quality of life, mental health, social reintegration, work, family, everyday life, access to services and the feeling that no person is left alone after diagnosis or treatment.

Through its participation in European networks such as INE-CSC, Kapa3 continues to contribute to the dialogue on more equitable, participatory and person-centred cancer care. Care that uses technology without losing sight of the human being at its centre.

The future of cancer support will not depend only on better digital tools, but on better collaboration between patients, caregivers, healthcare professionals, researchers, technology partners, patient organisations and policymakers.

For Kapa3, this is at the heart of its mission: transforming knowledge into action, technology into support, and the voice of patients into services that respond to their real needs.

More information: INE-CSC – Implementation Network Europe for Cancer Survivorship Care.More information:
https://inecancersurvivorship.com

Bladder Cancer Awareness Month: Awareness, prevention and early diagnosis

May is internationally recognized as Bladder Cancer Awareness Month, an important initiative led by health organizations and patient advocacy groups worldwide to promote public awareness, prevention, and early diagnosis.

Bladder cancer is among the most common types of cancer globally, with hundreds of thousands of new cases diagnosed each year. In Europe, it is considered one of the most common urological cancers, affecting men significantly more often than women.

In Greece, the data remains particularly concerning. The country records the highest incidence rate in Southern Europe, with approximately 39.7 new cases per 100,000 men annually. In terms of mortality, an estimated 7–8 men per 100,000 lose their lives to the disease every year, placing Greece among the countries with the highest mortality rates in the region. These figures highlight the importance of prevention, awareness, and timely medical intervention.

Behind every statistic are people — patients and families facing the emotional, physical, and practical challenges that accompany a cancer diagnosis. Raising awareness is therefore not only about numbers, but also about supporting individuals throughout their journey.

Smoking remains the most significant risk factor for bladder cancer and is linked to a large percentage of cases. Long-term exposure to certain chemicals, especially in specific occupational environments, as well as chronic inflammation of the urinary tract, may also increase the risk of developing the disease.

Recognizing the symptoms early can make a critical difference. The most common warning sign is blood in the urine (hematuria), even when no pain is present. Other symptoms may include frequent urination, burning during urination, or a sudden urge to urinate. Although these symptoms may also be associated with less serious conditions, they should never be ignored.

When bladder cancer is diagnosed at an early stage, survival rates are significantly higher, underlining the importance of early detection. However, the disease is also known for its high recurrence rates, making long-term follow-up and monitoring essential even after treatment.

Prevention remains a key pillar in reducing the burden of the disease. Quitting smoking, limiting exposure to harmful chemicals, and increasing awareness of the symptoms can all contribute to lowering the risk.

In Greece, awareness initiatives are also supported by scientific organizations such as the Hellenic Genito-Urinary Cancer Group (HGUCG), contributing to public education and the promotion of early symptom recognition.

Bladder Cancer Awareness Month is an important opportunity to encourage open discussion around the disease. Awareness is more than information — it is a tool that can lead to earlier diagnosis, improved treatment outcomes, and ultimately, more lives saved.

Sources:

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Kapa3 in the second half of April: Information, collaborations and strengthening patient care

Kapa3 in April

Throughout April, Kapa3 continued to develop actions and initiatives aimed at improving access to care for oncology patients and their families, with a strong focus on information, prevention, and the development of innovative collaborations.

This period’s activities focused on raising awareness about key cancer types, improving patients’ daily lives through policy and systemic developments, and expanding partnerships that enhance the quality of care and services provided.

In an ever-evolving healthcare environment, the connection between reliable information, human support, and technology remains a key pillar for a more accessible and effective care system.

Below are the main initiatives and developments that marked the second half of the month.

Awareness

April is an awareness month for head and neck cancer as well as testicular cancer, highlighting the importance of prevention and early diagnosis. Although these types of cancer are often underrepresented in public discourse, awareness plays a crucial role in reducing late diagnoses and improving patients’ quality of life.

Patients’ rights

Important developments took place in the field of patients’ rights, including the establishment of the National Registry for Hospital-at-Home Care (NOSPI), aiming to better organise and ensure the safety of home-based care.

At the same time, the new framework for Public Administration introduces changes that directly affect citizens’ daily lives, enhancing transparency, reducing bureaucracy, and improving access to public services.

Collaborations

During April, Kapa3 further strengthened its network of collaborations through significant partnerships.

The collaboration with the PRAXI Network/FORTH, within the European smartHEALTH hub, enhances participation in innovation and health policy initiatives, opening new opportunities at European level.

In addition, the partnership with Karkinaki focuses on supporting children, adolescents, and families living with cancer, promoting a holistic approach to care.

Furthermore, the collaboration with SimasiaAI for the development of “Myrto”, an AI-powered digital assistant, highlights the importance of technology in empowering patients and improving access to reliable information and services.

Research & knowledge

A new international report on person-centred cancer care highlights the need for a holistic model that places the patient at the centre. This approach recognises not only clinical needs but also psychosocial dimensions, reinforcing the importance of patient involvement in decision-making.

Patients & society

On the occasion of European Patients’ Rights Day (18 April), Kapa3 highlighted the importance of equal access to quality care. Despite progress, challenges such as inequalities and delays remain, making the continued strengthening of support structures essential.

Supporting our work

Kapa3’s collection of handmade scarves continues to serve as a creative way of supporting the organisation’s mission, combining aesthetics with meaningful contribution to people living with cancer.

We continue to monitor developments and work towards improving patients’ daily lives — more news coming soon.

Text/adaptation: Ifigenia Anastasiou for Kapa3

MELODIC Online Symposium: completion of the pilot training phase and strengthening psychosocial cancer care

The European project MELODIC (Mental Health Support for Young Adults with Cancer), in which the Cancer Guidance Center – Kapa3 participates, is being implemented through distinct development phases. The pilot training programme for healthcare professionals is one of its core components, and within this framework, the MELODIC Online Symposium 2026, taking place on 24 April 2026, marks the completion of this educational phase.

The MELODIC project framework

MELODIC is a European project co-funded by the European Union, aiming to strengthen the mental health of young adults living with cancer, as well as to support their families. Through the collaboration of universities, research institutions and healthcare organizations across Europe, the project develops training and support tools for healthcare professionals.

More information about the project and its progress is available on the official Kapa3 website, in the dedicated project section.

The pilot training programme

The pilot training programme focused on enhancing the knowledge and skills of healthcare professionals in providing psychosocial support to young adults with cancer and their families.

As part of the programme, online sessions and contact lessons were delivered, aiming to strengthen interdisciplinary collaboration and support the practical application of tools in everyday clinical practice.

MELODIC Online Symposium 2026

The MELODIC Online Symposium 2026, a two-hour event, brings together participants from all partner countries and includes:

  • opening presentations from the European Cancer Organisation and Youth Cancer Europe
  • an “experts by experience” panel, where individuals share their lived experience
  • a networking panel with healthcare professionals from participating countries
  • discussion on how training can be applied in clinical practice
  • a closing session by the project coordination team

From training to clinical practice

A key objective of the MELODIC training programme is to strengthen the psychosocial dimension of cancer care, with particular focus on young adults.

The exchange of experiences among healthcare professionals contributes to more holistic approaches to care and supports the integration of psychosocial support into daily clinical practice.

The role of Kapa3

Kapa3 actively participates in the European MELODIC consortium, contributing to the implementation of the training activities and the dissemination of results in Greece. Through this involvement, the connection between scientific knowledge and the support of cancer patients is further strengthened, promoting the development of practical approaches to psychosocial care.

The MELODIC Online Symposium 2026 marks the transition from the pilot training phase to the next stage of utilizing its outcomes, reinforcing the link between education and real-world application in cancer care.

The Press Release here: PRESS-RELEASE-MELODIC SYMPOSIUM

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Kapa3 in the First Half of March: Actions, Collaborations, and Updates for Oncology Patients

During the first half of March, Kapa3 continued to highlight important topics concerning the oncology patient support, rights, and daily lives  through initiatives, collaborations, and informational activities.

Efforts focused both on strengthening access to information and services, and on promoting practical and digital tools that make patients’ daily lives easier.

In an environment where patients’ needs remain complex and constantly evolving, reliable information, enhanced collaboration among stakeholders, and the promotion of holistic care are especially important.

Below is a summary of the main developments from the month.

Collaborations

Key partnerships were strengthened with the Sarcoma Fighters Patients Association, the Hellenic Federation of Persons with Multiple Sclerosis (HFoPwMS), and Doctor Homie, aiming to enhance information, support, and quality care for patients.

Actions & Presentations

Kapa3 participated in the scientific meeting “Cancer in 2026: Challenges and Breakthroughs,” emphasizing the pivotal role of supportive care for oncology patients, while also presenting recent developments addressing their evolving needs. Kapa3 also attented the event “Facing the Challenge of Artificial Intelligence” as we remain focused on supporting dialogue around the opportunities and challenges of A.I.

Patient Rights

Supporting oncology patients remains a central goal of our initiatives. Focus was given to updates on the 2026 constant attendance allowance and improved digital access for patients to their test results.

Digital Health & Research

A new European Commission report highlights the critical role of digital health technologies in transforming healthcare systems, outlining both opportunities and challenges for the future of care.

Awareness

March is Colorectal Cancer Awareness Month, reminding everyone of the importance of prevention and early detection.

Oncology patient support remains our top priority, and we continue to monitor developments — more news will follow.

Kapa3 at the Scientific Meeting “Cancer in 2026: Challenges and Disruptions” – Focusing on Supportive Care and Its Limits

At the scientific meeting “Cancer in 2026: Challenges and Disruptions”, held on March 13–14, 2026 at the Divani Caravel, Kapa3 actively contributed to discussions on supportive care for oncology patients, a critical area for improving quality of life and holistic patient support.

The meeting was organized by the Hellenic Oncology Patient Support Institute, under the chairmanship of Christos Panopoulos, and was held under the auspices of the Hellenic Cancer Society and the Hellenic Society of Medical Oncologists. It has become a recognized annual event for the oncology community, highlighting each year the latest challenges and rapid developments in the field.

Progress in oncology is continuous and impressive, with scientific advances steadily enhancing the possibilities for personalized treatment, while simultaneously improving patients’ quality of life and turning some forms of cancer into manageable chronic conditions.

During the two-day meeting, key developments were presented in critical areas such as precision medicine, immunotherapy, and novel therapeutic strategies, with particular emphasis on the role of artificial intelligence and molecular analysis in modern clinical practice.

Kapa3 participated in the roundtable on supportive care for oncology patients, held on Friday, March 13, represented by Ms. Evangeli Bista. She noted that attending the conference gave her the opportunity to engage with people leading initiatives in patient support and advocacy. The roundtable addressed critical topics such as the role of healthcare professionals, pain management in Greece, and the adequacy of existing care structures.

In the discussion on psychosocial support, Ms. Bista, representing Kapa3 and drawing from her daily experience with oncology patients, emphasized that addressing the challenges arising from the patient journey is particularly demanding, as the high volume of cases and the fragmentation of the healthcare and social support system create exponentially more issues to manage.

When asked whether voluntary work alone is sufficient to meet the growing needs of patients, her response was clear:

…voluntary action is a valuable and essential pillar of social support. The improvement of patients’ quality of life relies heavily on voluntary efforts that take place across the country under challenging conditions. However, it is not sufficient on its own to meet the complex and increasing needs of patients.

As highlighted during the discussion, voluntary contributions are crucial for filling gaps in the system and strengthening social protection. At the same time, a more comprehensive and institutionally supported approach is necessary. This includes:

• adequate and stable funding
• continuous training and empowerment of all stakeholders
• clear and functional legal frameworks
• a shift in mindset among healthcare professionals, patients, and administrators
• and the development of integrated policies in the field of supportive care

Kapa3’s intervention underscored the importance of psychosocial support as an integral part of oncology supportive care, promoting a more holistic, humane, and sustainable approach to patient management. As Ms. Bista noted, participating in the two-day meeting serves as a reminder that the fight to support patients requires all of us on the same side.

March – Multiple Myeloma Awareness Month

March – Multiple Myeloma Awareness Month

March is internationally recognized as Multiple Myeloma Awareness Month, a type of blood cancer that affects plasma cells – immune system cells responsible for producing antibodies and defending the body against infections.

This period provides an important opportunity to raise public awareness, highlight the challenges faced by patients, and enhance understanding of the disease, early diagnosis, and the importance of access to modern treatments.

What is Multiple Myeloma

Multiple myeloma develops in the bone marrow, when plasma cells grow uncontrollably and produce abnormal proteins. The presence of these cells can affect the production of healthy blood cells, cause bone damage, and impair the function of vital organs such as the kidneys. Although relatively rare, it is the second most common blood cancer worldwide.

The disease’s symptoms may be initially nonspecific and develop gradually. Fatigue, bone pain – especially in the spine or ribs – frequent infections, anemia, or kidney problems are some of the signs that may prompt further investigation. Early awareness and timely medical evaluation are therefore crucial for diagnosis and disease management.

Multiple Myeloma by the Numbers

Globally, the disease affects a significant number of people. According to international epidemiological data:

  • 188,000 new cases were reported worldwide in 2022

  • Approximately 121,000 people died from the disease the same year

  • It is estimated that more than 540,000 people are currently living with multiple myeloma worldwide

The disease occurs more often in older adults. Most diagnoses occur in people over 60–65 years old, and around 80% of cases are reported in individuals over 65. Experts predict that the disease’s incidence may rise in the coming decades, largely due to the aging population in many countries.

The Situation in Greece

In Greece, the exact epidemiological picture of multiple myeloma is not fully clear, as there is no comprehensive national cancer registry recording all cases systematically.

However, according to available international estimates for 2022:

  • About 763 new multiple myeloma cases were reported in the country

  • Approximately 579 deaths were attributed to the disease

  • It is estimated that around 2,154 people in Greece are living with the disease over a five-year period

These figures highlight the importance of improving health data collection and continuously supporting patients living with the disease.

Advances in Treatments

In recent years, scientific progress has significantly changed the course of the disease.

Modern therapies include:

  • Immunotherapies

  • Monoclonal antibodies

  • Proteasome inhibitors

  • Immunomodulatory drugs

  • CAR‑T cell therapies (for advanced stages of the disease)

New therapeutic combinations and ongoing clinical studies are providing more treatment options, reinforcing hope for even more effective therapies in the future.

The Importance of Awareness and Support

Despite these advancements, public awareness and support for people living with the disease remain crucial. Early diagnosis, access to specialized medical care, and equitable access to modern therapies are key factors in improving disease outcomes and patients’ quality of life.

Multiple Myeloma Awareness Month serves as a reminder that knowledge, research, and collective effort can make a difference. Through education, support for scientific research, and assistance to patients and their families, we can help create an environment where no one faces cancer alone.

Sources:

https://gco.iarc.fr
(Global Cancer Observatory – International Agency for Research on Cancer)

https://pubmed.ncbi.nlm.nih.gov/39658225/
(Global burden and projections of multiple myeloma)

https://www.oecd.org/health/cancer-profiles/greece.html
(EU Country Cancer Profile – Greece)

https://ehoonline.biomedcentral.com/articles/10.1186/s40164-025-00684-x
(Global epidemiology of multiple myeloma)

https://pmc.ncbi.nlm.nih.gov/articles/PMC3627436/
(Multiple myeloma epidemiology study)

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Cancer: From Prevention to Life Coordination – Successful Knowledge Seminar in Megara with Kapa3

With great success and participation from citizens of all ages, the Knowledge Seminar in Megara – From Prevention to Life Coordination took place on Sunday, February 8, in the Council Chamber of the Megara City Hall, in celebration of World Cancer Day.

The event was organized by the Municipality of Megara in collaboration with the Kapa3 Cancer Guidance Center, which since 2020 provides guidance and support to oncology patients and their families, ensuring access to vital information and services.

The seminar opened with a speech by the Mayor of Megara, Panagiotis Margetis, who shared his family’s personal experience with cancer, emphasizing the importance of accurate information and support throughout the patient journey. Stamatis Georgakis, Deputy Mayor for Public Health and Social Protection, coordinated the seminar and highlighted the value of Kapa3 and its Guidance Station in informing, supporting, and advocating for patients’ rights.

Distinguished experts participated in the seminar, presenting key aspects of holistic cancer care:

  • Georgios Nintos, MD MSc, Oncologist: Prevention and early diagnosis, causes, and preventive measures.

  • Katerina Papakonstantinou, MD MSc PhD, Obstetrician-Gynecologist: Gynecologic cancer, importance of HPV vaccination and Pap test.

  • Andrea Paola Rochas, Assistant Professor of Biology, University of Peloponnese Nursing Department: Nutrition and cancer prevention, emphasizing the Mediterranean diet, exercise, and avoidance of processed foods.

  • Maria Lavdaniti, Professor and Head of Nursing Department, International University: Role of oncology nurses in holistic care.

  • Pinelopi Vlotinou, Assistant Professor of Occupational Therapy, University of West Attica: Daily living support and quality-of-life improvement through occupational therapy.

  • Ioanna Sideri, Psychologist MSc, PhD(c), University of Peloponnese: Psychological support for patients and caregivers, resilience, and crisis management.

  • Grigoria Zacharogianni, MD MSc PhD, Radiation Oncologist: Modern treatment options and importance of moderate exercise during therapy.

The presentation of Kapa3 was delivered by Evangelia Bista, Co-founder and Head of Strategic Partnerships, highlighting the importance of digital literacy and a holistic approach to patient care. Kapa3 has expanded its oncology support network by inaugurating the Cancer Guidance Station in Megara, with the significant support of Megara Resins. In its first year, the station has assisted over 100 beneficiaries, offering guidance on social rights, patient file management, and psychological support, free of charge.

For 2026, Kapa3 is strengthening its digital services with Myrto, Greece’s first AI-powered Health Digital Assistant, providing personalized guidance and voice control. Planned initiatives also include: Wellness in Motion, with 12 outdoor walks for mental wellbeing of young adult cancer patients, the Cancer Wellness Open House Day, and a conference on equitable access to care.

The Knowledge Seminar in Megara – From Prevention to Life Coordination highlighted the importance of prevention, holistic care, interdisciplinary collaboration, digital literacy, psychological support, and continuous patient rights education.

Kapa3 warmly thanks the Municipality of Megara for hosting and supporting the event, as well as all speakers, for their invaluable expertise and commitment to sharing knowledge and scientific know-how.

Explore the photo gallery here:

The Press Release document here

World Cancer Day: United by Our Uniqueness

Every year on 4 February, World Cancer Day invites us to reflect on one of the greatest challenges of modern public health.

The goal is not only to confront cancer as a disease, but to face it with knowledge, empathy and shared responsibility. Because cancer touches millions of lives in countless ways, yet it does not define who we are. We are more than a diagnosis, more than a number.

World Cancer Day was established in 2000, following the World Summit Against Cancer for the New Millennium in Paris. It is a core element of the Paris Charter Against Cancer — a global commitment to advancing research, prevention, patient care, awareness and international mobilisation. Since then, the day has served as a reminder that addressing cancer requires long-term vision, cooperation and consistency.

This year’s message, “United by Unique”, highlights a fundamental truth: cancer is not only a medical event.

It is a deeply personal experience. Behind every diagnosis lies a unique human story — stories of fear and loss, but also of resilience, care, love and healing. Every story counts.

Cancer Today: Facts and Challenges

Cancer remains one of the most significant public health challenges in Europe and in Greece. Data from international and European organisations underline not only the scale of the disease, but also the persistent inequalities in prevention, early detection and access to care.

In Europe, approximately 2.7 million new cancer diagnoses are recorded each year, with around 1.3 million deaths, while the economic burden exceeds €93 billion annually. In Greece, cancer is the second leading cause of death, affecting thousands of families and carrying profound social and psychological consequences.

Progress, Prevention and Hope

At the same time, scientific progress offers well-founded reasons for optimism.

Prevention and early detection remain decisive factors. Screening programmes, vaccination, healthy lifestyle choices and access to reliable information can significantly reduce the risk of certain cancers and improve treatment outcomes. In this context, knowledge is not merely information — it is power and a fundamental right.

Advances in cancer management are equally important. Personalised medicine, targeted therapies, immunotherapy and improved management of treatment side effects contribute not only to increased survival rates, but also to a better quality of life for people living with and beyond cancer. Information and education are key tools for both prevention and empowerment.

Mental health plays a crucial role as well. Diagnosis and treatment are often accompanied by anxiety, fear, sadness and emotional exhaustion — affecting not only patients, but also their caregivers. Psychosocial support, counselling services and empowerment groups are essential components of holistic cancer care, helping to preserve dignity and quality of life.

Information, research and mental health care are core pillars of modern cancer management. Indicatively, you may explore the following Kapa3 articles:

Empowerment and Action

World Cancer Day is not just a day of awareness. It is a call to action:

  • to speak openly about prevention and our health,

  • to support people living with cancer and their caregivers,

  • to seek reliable information and evidence-based sources,

  • to advocate for equal access to care and psychological support,

  • to remember that no one should face cancer alone.

Because our strength lies in solidarity — and in respecting the uniqueness of every individual.

United by our uniqueness.

References:

World Health Organization (WHO) – Cancer
https://www.who.int/health-topics/cancer

International Agency for Research on Cancer (IARC)
https://www.iarc.who.int

Union for International Cancer Control (UICC) – World Cancer Day
https://www.worldcancerday.org

European Commission – Europe’s Beating Cancer Plan
https://health.ec.europa.eu/eu-policy/health-strategies/europes-beating-cancer-plan_en

European Cancer Information System (ECIS)
https://ecis.jrc.ec.europa.eu

Hellenic Statistical Authority (ELSTAT) – Health Data
https://www.statistics.gr/en/statistics/-/publication/SHE15/

Hellenic National Public Health Organization (EODY) – Cancer & Public Health
https://eody.gov.gr/

Greek Ministry of Health – Prevention & Screening
https://www.moh.gov.gr/articles/prevention-screening

Text/adaptation: Ifiyenia Anastasiou for Kapa3